4
Changes in Ownership
Disc Medicine, Inc. Filed Acc 0000950170-24-138086
Chief Executive Officer sold 12,791 shares at an average $66.01 ($844,314)
- Chief Executive Officer acquired 12,791 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Quisel John D · Chief Executive Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +12,791 | $1.01 | $12,919 | 84,856 | D |
| 2024-12-16 | Sale : show line 2 in the form 10b5-1 | −219 | $64.66 | $14,160 | 84,637 | D |
| 2024-12-16 | Sale : show line 3 in the form 10b5-1 | −5,767 | $65.58 | $378,194 | 78,870 | D |
| 2024-12-16 | Sale : show line 4 in the form 10b5-1 | −6,305 | $66.35 | $418,361 | 72,565 | D |
| 2024-12-16 | Sale : show line 5 in the form 10b5-1 | −500 | $67.20 | $33,599 | 72,065 | D |
| Open-market sales · 12,791 sh · avg $66.01 · $844,314 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-12-16 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −12,791 | 225,420 | D |
Loading xslF345X05/ownership.xml…